Drug Store News sat down with Chester “Chip” Davis, president and CEO of the Association for Accessible Medicines, to discuss how the generics industry is adapting to a changing market, and new opportunities manufacturers may be looking to pursue.
Packaging is the distillation of the brand’s identity and purpose, so it’s essential to understand the regulatory constraints very early on in the brand design process.
Alex Azar was president of Eli Lilly from 2012 until January 2017, having joined the company in 2007 as senior vice president of corporate affairs and communications.
Prohibited under the S1 Anabolic Agent category of the World Anti-Doping Agency Prohibited List, SARMs have raised serious concerns for FDA, USADA and the legitimate dietary supplement industry.
The NIH is currently researching a "precision medicine" approach to managing diabetes, where a person’s genes, environment, lifestyle and other factors all help determine the best treatment plan.
The report, issued at the commission’s final meeting Wednesday, includes recommendations that were part of suggestions made to the Administration by industry organizations.
Amarin requested that ITC issue a general exclusion order prohibiting the importation of the fish oils.
Shingrix was approved by the US Food and Drug Administration on Oct. 20 for use in adults aged 50 years and older.
The National Association of Chain Drug Stores has penned a letter outlining four potential policy efforts aimed at building on current collaborative efforts to stem opioid abuse, while maintaining high-quality patient care.
State Rep. Jay Trumbull, representing Florida’s 6th District, is just one of the legislators supporting his local independent pharmacy, Coopers Drugs in Panama City.